OC-0599 Factors Associated with SBRT Doses in Oligometastatic Disease: an EORTC/ESTRO OligoCare AnalysisM. Guckenberger,F. Alongi,U. Ricardi,M. Scorsetti,P. Balermpas,L. Livi,Y. Lievens,P. Braam,B. A. Jereczek-Fossa,K. Stellamans,I. Ratosa,H. Peulen, J. Widder,S. Ramella,L. Verbeke,P. Dirix,K. Khanfir,T. Zilli,H. Hemmatazad,P. Jeene,G. B. Ivaldi,E. Clementel,B. Fournier,C. Fortpied,P. OstRADIOTHERAPY AND ONCOLOGY（2022）引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
